Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine Schedules in Poor Prognosis Advanced NSCLC
NCT00022009Phase 3Unknown
- Sponsor
- The Christie
- Start
- Jul 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gemcitabine in non-small cell lung cancer (NSCLC), sponsored by The Christie. Status: unknown.
02
Drugs
gemcitabine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00022009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00022009.